Literature DB >> 11287880

Serratia marcescens transmission in a pediatric intensive care unit: a multifactorial occurrence.

M L Manning1, L K Archibald, L M Bell, S N Banerjee, W R Jarvis.   

Abstract

BACKGROUND: Fourteen patients in the pediatric cardiac intensive care unit (CICU) had > or =1 positive culture for a single strain of Serratia marcescens from April through December 1995 (study period).
OBJECTIVES: To identify risk factors for S marcescens infection or colonization in a pediatric CICU.
METHODS: Retrospective case-control study. Assessment of CICU infection control practices and patient exposure to CICU health care workers (HCWs). Epidemiologic-directed cultures of the environment and HCWs' hands were obtained.
SETTING: Pediatric CICU. PATIENTS: Fourteen patients in the pediatric CICU had > or =1 positive culture for a single strain of S marcescens from April through December 1995 (study period). CICU patients who did not have S marcescens infection or colonization during the study period were randomly selected as controls.
RESULTS: A case patient was more likely than a noncase patient to have exposure to a single HCW (odds ratio [OR], 19.5; 95% CI, 2.6-416; P<.003); however, this association was not adequately explained by epidemiologic or microbiologic studies. Interviews suggested that during the outbreak period, handwashing frequency among HCWs might have been reduced because of severe hand dermatitis.
CONCLUSIONS: A combination of factors, including breaks in aseptic technique, reduced frequency of handwashing among HCWs before and between caring for patients, decreased attention to infection control practices, and environmental contamination may have indirectly contributed to this S marcescens infections outbreak.

Entities:  

Mesh:

Year:  2001        PMID: 11287880     DOI: 10.1067/mic.2001.114222

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  8 in total

Review 1.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

2.  Recurrent outbreaks of Serratia marcescens among neonates and infants at a pediatric department: an outbreak analysis.

Authors:  B Ivády; D Szabó; I Damjanova; M Pataki; M Szabó; É Kenesei
Journal:  Infection       Date:  2014-07-12       Impact factor: 3.553

3.  Diversity of bacterial communities of fitness center surfaces in a U.S. metropolitan area.

Authors:  Nabanita Mukherjee; Scot E Dowd; Andy Wise; Sapna Kedia; Varun Vohra; Pratik Banerjee
Journal:  Int J Environ Res Public Health       Date:  2014-12-03       Impact factor: 3.390

4.  An Outbreak of Serratia marcescens in a Moroccan Neonatal Intensive Care Unit.

Authors:  Abdellatif Daoudi; Fatiha Benaoui; Nadia El Idrissi Slitine; Nabila Soraa; Fadl Mrabih Rabou Maoulainine
Journal:  Adv Med       Date:  2018-11-01

Review 5.  Current and emergent strategies for disinfection of hospital environments.

Authors:  Ana C Abreu; Rafaela R Tavares; Anabela Borges; Filipe Mergulhão; Manuel Simões
Journal:  J Antimicrob Chemother       Date:  2013-07-18       Impact factor: 5.790

6.  Evaluation of loop-mediated isothermal amplification assays for rapid detection of blaKPC producing Serratia spp. in clinical specimens: A prospective diagnostic accuracy study.

Authors:  Xinwei Liu; Dayang Zou; Chunxia Wang; Xiaoqian Zhang; Dongxu Pei; Wei Liu; Yongwei Li
Journal:  Exp Ther Med       Date:  2021-02-01       Impact factor: 2.447

7.  Prolonged outbreak of Serratia marcescens in Tartu University Hospital: a case-control study.

Authors:  Vivika Adamson; Piret Mitt; Heti Pisarev; Tuuli Metsvaht; Kaidi Telling; Paul Naaber; Matti Maimets
Journal:  BMC Infect Dis       Date:  2012-10-31       Impact factor: 3.090

8.  Are we aware how contaminated our mobile phones with nosocomial pathogens?

Authors:  Fatma Ulger; Saban Esen; Ahmet Dilek; Keramettin Yanik; Murat Gunaydin; Hakan Leblebicioglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-03-06       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.